• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内暴露于硫唑嘌呤和通过母乳喂养的婴儿的长期随访。

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.

机构信息

Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria.

出版信息

J Crohns Colitis. 2011 Apr;5(2):95-100. doi: 10.1016/j.crohns.2010.10.005. Epub 2010 Dec 9.

DOI:10.1016/j.crohns.2010.10.005
PMID:21453877
Abstract

BACKGROUND

Recommendations on breastfeeding under thiopurines are inconsistent due to limited data.

AIM

To assess the risk of infections in offspring breastfed by mothers receiving azathioprine (AZA) for inflammatory bowel disease (IBD).

METHODS

Babies, who were breastfed from their mothers treated either with or without AZA were included from a local pregnancy-registry. Women were asked by structured personal interview on general development, infections, hospitalisations and vaccinations of their offspring.

RESULTS

A group of 11 mothers taking AZA (median 150 mg/d) during pregnancy and lactation and another of 12 patients without using any immunosuppressive therapy breastfed 15 babies each for median 6 months and 8 months, respectively. Median age of children at time of interview was 3.3 and 4.7 years, respectively. All offspring showed age-appropriate mental and physical development. Infections were commonly seen childhood diseases. Similar rates were observed for most of the various infections between offspring with and without azathioprine exposure during breastfeeding. However, common cold more than two episodes/year and conjunctivitis were numerically more often reported in the group without AZA exposure. In an exploratory analysis no difference in the rate of hospitalisations was seen between exposed (0.06 hospitalisations/patient year) versus non-exposed children (0.12 hospitalisations/patient year, p=0.8)

CONCLUSION

Our study which reports the largest number of babies breastfed with exposure to AZA suggests that breastfeeding does not increase the risk of infections.

摘要

背景

由于数据有限,关于硫唑嘌呤下母乳喂养的建议不一致。

目的

评估接受硫唑嘌呤(AZA)治疗炎症性肠病(IBD)的母亲母乳喂养的婴儿感染的风险。

方法

从当地妊娠登记处纳入了接受或不接受 AZA 治疗的母亲母乳喂养的婴儿。通过结构化个人访谈,询问女性关于其子女的一般发育、感染、住院和疫苗接种情况。

结果

一组 11 名母亲在妊娠和哺乳期服用 AZA(中位数 150mg/d),另一组 12 名患者未使用任何免疫抑制疗法,分别母乳喂养了 15 名婴儿,中位数为 6 个月和 8 个月。访谈时儿童的中位数年龄分别为 3.3 岁和 4.7 岁。所有子女均表现出与年龄相适应的精神和身体发育。感染是常见的儿童疾病。在母乳喂养期间接受和未接受 AZA 暴露的婴儿中,大多数各种感染的发生率相似。然而,在未接受 AZA 暴露的组中,普通感冒的次数(每年超过 2 次)和结膜炎的次数较多。在探索性分析中,未观察到暴露组(0.06 次住院/患者年)与非暴露组(0.12 次住院/患者年,p=0.8)之间的住院率存在差异。

结论

我们的研究报告了接受 AZA 暴露母乳喂养的婴儿数量最多,这表明母乳喂养不会增加感染的风险。

相似文献

1
Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.宫内暴露于硫唑嘌呤和通过母乳喂养的婴儿的长期随访。
J Crohns Colitis. 2011 Apr;5(2):95-100. doi: 10.1016/j.crohns.2010.10.005. Epub 2010 Dec 9.
2
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
3
Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.炎症性肠病女性孕期使用硫唑嘌呤治疗时胎儿的宫内暴露的长期随访。
Aliment Pharmacol Ther. 2013 Jul;38(1):38-43. doi: 10.1111/apt.12334. Epub 2013 May 16.
4
Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.预测炎症性肠病患儿初诊时对硫唑嘌呤的需求。
J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):123-9. doi: 10.1097/MPG.0b013e318156a834.
5
[Azathioprine in inflammatory bowel disease].[硫唑嘌呤在炎症性肠病中的应用]
Acta Med Port. 2009 Jan-Feb;22(1):33-40. Epub 2009 Mar 25.
6
Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.硫唑嘌呤治疗溃疡性结肠炎患者的淋巴瘤风险:一项全国性回顾性队列研究。
Gastroenterology. 2013 Nov;145(5):1007-1015.e3. doi: 10.1053/j.gastro.2013.07.035. Epub 2013 Jul 25.
7
Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.炎症性肠病患者的生育力、妊娠结局及母乳喂养:一项大型队列调查
Scand J Gastroenterol. 2013 Apr;48(4):427-32. doi: 10.3109/00365521.2013.772229. Epub 2013 Mar 11.
8
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.早期使用硫唑嘌呤/生物制剂治疗与克罗恩病患者(无论是否吸烟)首次手术风险降低和手术时间延迟有关,但不增加再次手术风险,而吸烟则降低溃疡性结肠炎患者结肠切除术的风险。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):872-9. doi: 10.1097/MEG.0b013e32833036d9.
9
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.硫唑嘌呤用于溃疡性结肠炎的维持治疗:停药后的结局及预测因素
Am J Gastroenterol. 2009 Nov;104(11):2760-7. doi: 10.1038/ajg.2009.410. Epub 2009 Jul 21.
10
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.炎症性肠病患者中淋巴瘤和免疫调节剂的风险:来自东欧基于人群队列的结果。
J Crohns Colitis. 2013 Jun;7(5):385-91. doi: 10.1016/j.crohns.2012.06.011. Epub 2012 Jul 4.

引用本文的文献

1
Safety of Drugs in Breastfeeding Women With CKD.慢性肾脏病哺乳期女性用药的安全性
Kidney Int Rep. 2025 Apr 27;10(7):2189-2201. doi: 10.1016/j.ekir.2025.04.038. eCollection 2025 Jul.
2
Pregnancy after orthotopic liver transplantation: a comprehensive review.原位肝移植后的妊娠:一项综述
Front Transplant. 2025 Jun 6;4:1581273. doi: 10.3389/frtra.2025.1581273. eCollection 2025.
3
Compatibility of Post-Kidney Transplant Immunosuppression Therapy with Lactation.肾移植后免疫抑制治疗与哺乳的兼容性。
J Clin Med. 2025 Mar 29;14(7):2364. doi: 10.3390/jcm14072364.
4
Effects of pregnancy on the clinical course and treatment outcomes of Vogt-Koyanagi-Harada disease.妊娠对Vogt-小柳-原田病临床病程及治疗结局的影响。
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S158-S163. doi: 10.4103/IJO.IJO_1251_24. Epub 2024 Oct 25.
5
Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications.结节病的临床药理学:如何使用和监测结节病药物
J Clin Med. 2024 Feb 22;13(5):1250. doi: 10.3390/jcm13051250.
6
The Fundamentals of Inflammatory Bowel Disease Management in Pregnancy: A Practical Review for the Gastroenterologist.妊娠期炎症性肠病管理的基本原则:胃肠病学家实用综述
J Can Assoc Gastroenterol. 2024 Jan 20;7(1):121-131. doi: 10.1093/jcag/gwad056. eCollection 2024 Feb.
7
Inflammatory bowel disease in pregnancy and breastfeeding.妊娠和哺乳期炎症性肠病。
Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):504-523. doi: 10.1038/s41575-023-00758-3. Epub 2023 Mar 31.
8
The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function.母体炎症性肠病和免疫调节剂对宫内暴露婴儿免疫系统发育和功能的影响。
Cell Mol Gastroenterol Hepatol. 2023;16(1):165-181. doi: 10.1016/j.jcmgh.2023.03.005. Epub 2023 Mar 25.
9
Pregnancy in Patients with Inflammatory Bowel Diseases-A Literature Review.炎症性肠病患者的妊娠——文献综述
Life (Basel). 2023 Feb 9;13(2):475. doi: 10.3390/life13020475.
10
Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.女性器官移植受者所生的胎儿和哺乳期免疫抑制暴露儿童的结局。
Paediatr Drugs. 2022 Sep;24(5):483-497. doi: 10.1007/s40272-022-00525-y. Epub 2022 Jul 23.